Product Recalls: September 13, 2023 – October 11, 2023
Health Letter, November 2023
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
CLASS I
Brexafemme tablets, 150 mg, 4 count cartons. Manufactured for and distributed by: Scynexis, Inc. Lot #: LF21000008, exp. date: 11/23; Lot #: LF22000051, exp. date: 11/25.
Digoxin tablets, 0.125 mg, 100-count bottles. Manufactured for/distributed by: Marlex Pharmaceuticals, Inc. Lot #: E3810, exp. date: 02/25; Lot #: E3811, exp. date: 02/25.
Wefun capsules, 825 mg, 1X10 blister pack per carton. Manufactured by: Wefun Inc. Lot #: 18520168, exp. date: 09/26.
CLASS II
Digoxin tablets, 0.25 mg, 100-count bottles. Manufactured for/distributed by: Marlex Pharmaceuticals, Inc. Lot #: E3811, exp. date: 02/25.
Oxybutynin Chloride Extended-Release tablets, 10 mg, 100 tablet and 500 tablet bottles. Manufactured by: Cadila Healthcare Ltd. Lot #: M300652 and M300651, exp. date: 12/24.
Rasagiline tablets, 0.5 mg, 30-count bottle. Manufactured by: Mylan Pharmaceuticals Inc. Lot #: 3112444, exp. date: 08/23.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.